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Sepsis is an age-old medical problem. Having first been
described by the ancient Greeks, it still troubles us today as one
of the most common causes of death in hospitalized patients,
with a mortality rate between 20 and 40%.1 Sepsis is an
umbrella term defining a systemic inflammatory response to
presumed or proven infection.2 Depending on the severity of
complications, sepsis can be further defined as severe sepsis
(complicated by remote organ dysfunction) or septic shock
(complicated by arterial hypotension).3 The initial clinical
diagnosis of sepsis is largely dependent on clinical history
and bedside examination, supplemented by diagnostic biomar-
kers such as blood C-response proteins, lactate levels, other
inflammatory markers, and ultimately demonstration of infective
cause by microbiological blood or other tissue cultures.1,3
These key microbiological tests in particular take some days to
complete. Certain patient groups are at particular risk of sepsis,
such as those with chronic conditions, such as cancer or
obesity, or patients undergoing immune-suppressive treat-
ments are more susceptible to sepsis.2 Often, however, young
healthy patients are also affected by severe sepsis, and it would
seem that there are unknown genetic or environmental factors.
Therefore, establishing novel rapid biomarkers of sepsis would
potentially be of great benefit to identify early stages for clinical
intervention, or to help high-risk populations that are suscep-
tible to severe sepsis or septic shock.
MicroRNAs (miRNAs) are a class of small noncoding RNAs
that are between 21 and 25 nucleotides in length. The primary
transcripts of miRNAs (pri-miRNAs) are transcribed by RNA
polymerase II, and processed into hairpins by Drosha-DGCR8
the microprocessor, then exported to the cytoplasm by
Exportin5.4 Once in the cytoplasm, they are recognised by
Dicer, which cleaves the hairpin structures into double-stranded
RNAs (dsRNAs). The dsRNAwill then be loaded onto one of the
Argonaute (Ago) family of proteins, which unwinds the dsRNA
structures and facilitate pairing betweenmiRNA to mRNA. Once
the miRNA is in complex with Ago proteins, they bind to target
sequences that are mainly located within the 3′ untranslated
region (UTR) of a target mRNA.4,5 Following target recognition,
miRNA in complex with the Ago protein promotes recruitment of
TNRC6 family proteins and theCcr4-NOT complex, which in turn
serve as docking sites for effector proteins.5 Recently, data from
several groups showed that this recruitment prevents the
message from being translated, by inhibiting eIF4F complex
scanning the 5′ UTR.6,7 Following that, the mRNA is then
decapped, deadenylated and degraded.6,7 Owing to the
importance and versatility of the miRNA pathway, some viruses
exploit thismechanism to benefit their propagation.Oneexample
is Hepatitis C virus (HCV) that hijacks miR-122 to facilitate the
replication of its viral RNA.8,9 Yet another example is KSHV that
produces 25 viral miRNAs. Among these miRNAs, miR-K12-11
can mimic host miR-155 resulting in aberrant regulation of some
key proteins in inflammatory response pathways.9
In the current issue ofCell Death and Disease, Tudor et al.11
look into the utility of miRNAs as diagnostic biomarkers in
sepsis. They screened for potential differences of miRNA
levels in the monocytes of eight healthy and sepsis patients
using miRNA microarray. After statistical analysis, a list of 10
cellular miRNAs and 2 viral miRNA were selected for clinical
studies. Among these miRNAs, they observed a downregula-
tion of miR-146 and miR-150 plasma levels in sepsis patients.
However, this was inconsistent between their cohorts.10 The
authors claim this may be attributed to differences in sepsis
etiology between cohorts. However, especially in the light of
conflicting results shown in a previous European study,11
larger scale population studies should be carried out to
confirm these findings, only then can one hope to use these
human miRNAs as potential biomarkers for sepsis.
Surprisingly, Tudor et al.10 also identify two viral miRNAs as
potential biomarker of sepsis, KSHV-miR-K12-10b and KSHV-
miR-K12-12*. Within both cohorts, it was observed that KSHV-
miR12-10b detection correlates well with the severity of
sepsis. In addition to this, they identified significant increases
in interleukin (IL)-6 and IL-10 plasma levels from sepsis
patients.10 Furthermore, this increase of plasma IL-6/10 level
also correlates well with the severity of sepsis in patients.10
This agrees with other reports claiming that plasma levels of
cytokines, especially IL-6, may serve as good prognostics
markers to predict the onset and outcome of sepsis.12,13 To
evaluate the relationship between KSHV-miR-K12-10b,
KSHV-miR-K12-12* and cytokine production, the authors
overexpress these two KSHV miRNAs in HEK293 cells.
Crucially, upon overexpression of either miRNA, they
observed an increase in secretion level of IL-6 and IL-10, at
a level that is comparable to lipopolysaccharide (LPS)
stimulation.10 Given that nearly half of sepsis cases are
triggered by Gram-negative bacterial infections and LPS is the
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major component of its outer membrane,14 this finding
suggests KSHV infection may be a potential cause of sepsis.
How do these KSHVmiRNAs contribute to the pathogenesis
of sepsis? The authors suggest that they may not function
through the canonical mechanism via post-transcriptional
repression of mRNA. Rather, they propose that these miRNAs
may serve as ligands for TLR8 and trigger a proinflammatory
response, similar to previous reports.15 To this end, they carried
out RNA-immunoprecipitation (RIP) experiment with Flag-
tagged TLR8 and observed an increased binding of KSHV-
miR-K12-10b and KSHV-miR-K12-12* to TLR8 compared with
other miRNAs.10 However, they did not carry out Ago2 RIP
experiment, nor investigate potential targets of these two
miRNAs. Thus, the possibility that thesemiRNAsmaymodulate
the host immune response by post-transcriptional regulation
should not be dismissed (see Figure 1 for a summary diagram).
As perioperative infection is a common cause of sepsis, the
authors questioned whether the increase of KSHV miRNA in
sepsis patients is correlated with surgery. Interestingly, using a
cohort consisting of nonsepsis patients, the authors observed a
significant increase of both KSHV-miR-K12-10b and KSHV-miR-
K12-12* plasma level in 71% of patients at post-operative
day 1.10 This spike of KSHV miRNA dissipated 7 days after
operation.10 Moreover, they observed a trend showing that the
increase of plasma KSHV miRNA level is greater in traditional
open abdominal surgery compared with minimally invasive
surgery.10 The authors suggest that surgical trauma may trigger
reactivation of latent KSHV in patients, resulting in a subsequent
increase of KSHV miRNA. It is known that KSHV prevalence is
variable, with serological positivity for KSH of up to 50% among
blood donors in Uganda as compared with 6% in the US.16,17
By any standard, the 71% KSHV miRNA positive rate at
post-operative day 1 is very surprising. This needs to be further
confirmed using larger patient cohorts and correlated with other
tests for KSHV infection, such as seropositivity. Is it possible that
surgical trauma is reactivating latent subclinical virus? It is known
that KSHV can contribute to malignancy, especially Kaposi’s
sarcoma. However, malignancy is a rare event after KSHV
infection. Therefore, the current finding by Tudor et al. that
potentially links KSHV to sepsis, warrants further investigation.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. W-TL is partially funded by MRC Centenary Award.
MB is funded by MRC and is a MRC Senior Fellow.
1. Bloos F, Reinhart K. Virulence 2014; 5: 154–160.
2. Mayr FB et al. Virulence 2014; 5: 4–11.
3. Angus DC, van der Poll T. N Engl J Med 2013; 369: 2063.
4. Ha M, Kim VN. Nat Rev Mol Cell Biol 2014; 15: 509–524.
5. Wilczynska A, Bushell M. Cell Death Differ 2014. 10.1038/cdd.2014.112.
6. Meijer HA et al. Science 2013; 340: 82–85.
7. Bazzini AA et al. Science 2012; 336: 233–237.
Figure 1 KSHV binds the EphrinA (EphA) receptor.18 Viral binding leads to viral internalization via endocytosis, resulting in the viral genome being released into the
nucleus.18 KSHV produces 25 viral miRNAs.9 Tudor et al.10 suggest that miR-K12-10b/12 may bind to TLR8 and activate cytokine production, in particular IL-6 and IL-10. It is
unknown whether these two viral miRNAs post-transcriptionally regulate any host mRNA. Nevertheless, KSHValso transcribes miR-K12-11, which shares the same sequence as
miR-155.9 This may induce the upregulation of TNFα proteins and further activation of the proinflammatory response, triggering sepsis
Editorial
2
Cell Death and Disease
8. Jopling CL et al. Science 2005; 309: 1577–1581.
9. Guo YE, Steitz JA. Mol Cell Biol 2014; 34: 3780–3787.
10. Tudor S et al. Cell Death & Disease 2014.
11. Rossato M et al. PNAS 2012; 109: E3101–E3110.
12. Gentile LF et al. Methods 2013; 61: 3–9.
13. Kuster H et al. Lancet 1998; 352: 1271–1277.
14. Cohen J. Nature 2002 Dec; 420: 885–891.
15. Fabbri M et al. PNAS 2012; 109: E2110–E2116.
16. Ganem D. J Clin Invest 2010; 120: 939–949.
17. Iscovich J et al. Cancer 2000; 88: 500–517.
18. Hahn AS et al. Nat Med 2012; 18: 961–966.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution 4.0 International
Licence. The images or other third party material in this article are
included in the article’s Creative Commons licence, unless indicated
otherwise in the credit line; if the material is not included under the
Creative Commons licence, users will need to obtain permission from
the licence holder to reproduce the material. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0
Editorial
3
Cell Death and Disease
